ArticleHealth science reports2026
Trends in Early-Onset Cancer Incidence Rates in Latin America: A Scoping Review Protocol.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Effectiveness, Safety, and Immunogenicity of a Second COVID-19 Vaccine Booster in the Elderly: A Systematic Review and Meta-Analysis Protocol.Health science reports · 2026Article
- Early-onset cancer in Latin America: incidence trends, evidence gaps and clinical implications.EClinicalMedicine · 2026Review
- Trends in Early-Onset Cancer Incidence Rates in Latin America: A Scoping Review Protocol.Health science reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/Aims: The global incidence of early-onset (EO) cancers-defined as malignancies diagnosed in individuals under the age of 50-has increased significantly over recent decades, particularly in high-income countries. However, epidemiological data from Latin America remain fragmented and underexplored. This study protocol describes a scoping review designed to systematically map and synthesize the available evidence on EO cancer incidence trends in Latin American populations. Methods: The review will be conducted in accordance with the JBI Manual for Evidence Synthesis and reported following PRISMA-ScR guidelines. A comprehensive search will be performed across multiple databases (PubMed, Embase, Scopus, LILACS, Cochrane, Web of Science), clinical trial registries, and gray literature sources without language or date restrictions. Studies reporting incidence data on solid tumors diagnosed before age 50 in Latin American countries will be included. Study selection and data extraction will be performed independently by four reviewers using a standardized form. Data will be analyzed through descriptive statistics and qualitative synthesis. The findings aim to highlight incidence patterns by cancer type, population characteristics, and methodological approaches. Results: The final scoping review will present the search results, the study inclusion process, and the data analysis. Conclusion: This review will provide a consolidated epidemiological overview to inform public health policy, improve cancer surveillance, and identify research gaps in the region. Review Registration: This protocol was registered on the Open Science Framework (OSF). The registry number is OSF.IO/TZ67D. This registration ensures the transparency and credibility of our research process, as it provides a public record of our study design and methods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.